TLR7 and early-onset autosomal dominant Alzheimer disease: Emerging evidence suggests that beyond its function as an immune receptor in immune cells, TLR7 also serves as a death receptor in various forms of non-infectious central nervous system (CNS) injury, such as ischemic stroke, Alzheimer’s disease, and morphine-mediated neurodegeneration [11, 13, 14].